Literature DB >> 6445877

Bacteriostatic enterochelin-specific immunoglobulin from normal human serum.

D G Moore, R J Yancey, C E Lankford, C F Earhart.   

Abstract

Heat-inactivated normal human serum produces iron-reversible bacteriostasis of a number of microorganisms. This inhibitory effect was abolished by adsorption of serum with ultraviolet-killed cells of species that produce the siderophore enterochelin. Bacteriostasis also was alleviated by adsorption of serum with 2,3-dihydroxy-N-benzoyl-L-serine, a degradation product of enterochelin, bound to the insoluble matrix AH-Sepharose 4B. The adsorption process did not add iron or enterochelin to serum, nor did it remove transferrin. The immunoglobulin fraction from normal human serum was isolated; when added to a defined medium (M199) prepared so as to mimic normal human serum, the immunoglobulin rendered the medium inhibitory to an enterochelin-defective strain of Salmonella typhimurium. Adsorption of this medium with AH-Sepharose 4B-2,3-dihydroxy-N-benzoyl-L-serine removed the inhibition. Our results indicate that enterochelin-specific immunoglobulins exist in normal human serum. These immunoglobulins may act synergistically with transferrin to effect bacteriostasis of enterochelin-producing pathogens.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6445877      PMCID: PMC550781          DOI: 10.1128/iai.27.2.418-423.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  The serum proteins in multiple myelomatosis.

Authors:  R A Kekwick
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

2.  Preparation of enterochelin from Escherichia coli.

Authors:  I G Young
Journal:  Prep Biochem       Date:  1976

Review 3.  Iron and infection.

Authors:  E D Weinberg
Journal:  Microbiol Rev       Date:  1978-03

4.  Enterochelin hydrolysis and iron metabolism in Escherichia coli.

Authors:  I G O'Brien; G B Cox; F Gibson
Journal:  Biochim Biophys Acta       Date:  1971-06-22

5.  Biologically active compounds containing 2,3-dihydroxybenzoic acid and serine formed by Escherichia coli.

Authors:  I G O'Brien; G B Cox; F Gibson
Journal:  Biochim Biophys Acta       Date:  1970-03-24

6.  Production by Salmonella typhimurium of 2,3-dihydroxybenzoylserine, and its stimulation of growth in human serum.

Authors:  T D Wilkins; C E Lankford
Journal:  J Infect Dis       Date:  1970-02       Impact factor: 5.226

7.  Glutaraldehyde-activated aminohexyl- derivative of Sepharose 4B as a new verstile immunoabsorbent.

Authors:  C L Cambiaso; A Goffinet; J P Vaerman; J F Heremans
Journal:  Immunochemistry       Date:  1975-04

8.  A one-tube method for measuring the serum iron concentration and unsaturated iron-binding capacity.

Authors:  H L Williams; M E Conrad
Journal:  J Lab Clin Med       Date:  1966-01

9.  The kinetics and mechanism of iron(3) exchange between chelates and transferrin. IV. The reaction of transferrin with iron(3) nitrilotriacetate.

Authors:  G W Bates; J Wernicke
Journal:  J Biol Chem       Date:  1971-06-10       Impact factor: 5.157

10.  Iron-Binding Catechols and Virulence in Escherichia coli.

Authors:  H J Rogers
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

View more
  18 in total

1.  Iron-regulated excretion of alpha-keto acids by Salmonella typhimurium.

Authors:  R Reissbrodt; R Kingsley; W Rabsch; W Beer; M Roberts; P H Williams
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

Review 2.  Siderophore-based iron acquisition and pathogen control.

Authors:  Marcus Miethke; Mohamed A Marahiel
Journal:  Microbiol Mol Biol Rev       Date:  2007-09       Impact factor: 11.056

3.  Iron and the outcome of infection.

Authors:  J H Brock
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

Review 4.  Acquisition, transport, and storage of iron by pathogenic fungi.

Authors:  D H Howard
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

5.  Aerobactin genes in clinical isolates of Escherichia coli.

Authors:  A Bindereif; J B Neilands
Journal:  J Bacteriol       Date:  1985-02       Impact factor: 3.490

6.  The growth-promoting effect of bacterial iron for serum-exposed bacteria.

Authors:  M W Mellencamp; M A McCabe; I Kochan
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

7.  Specific inhibition of Escherichia coli ferrienterochelin uptake by a normal human serum immunoglobulin.

Authors:  D G Moore; C F Earhart
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

8.  Bacteriostatic and fungostatic action of catecholamide iron chelators.

Authors:  R J Bergeron; G T Elliott; S J Kline; R Ramphal; L St James
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

9.  The ability of Salmonella typhimurium to produce the siderophore enterobactin is not a virulence factor in mouse typhoid.

Authors:  W H Benjamin; C L Turnbough; B S Posey; D E Briles
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

10.  Role of antibody and enterobactin in controlling growth of Escherichia coli in human milk and acquisition of lactoferrin- and transferrin-bound iron by Escherichia coli.

Authors:  J H Brock; M G Pickering; M C McDowall; A G Deacon
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.